GT Biopharma, Inc.GTBPNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank64
3Y CAGR-78.2%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-78.2%/yr
vs -4.0%/yr prior
Acceleration
-74.2pp
Decelerating
Percentile
P64
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.75 | +121.6% |
| 2024 | -3.46 | -351.4% |
| 2023 | 1.38 | -98.1% |
| 2022 | 72.16 | -38.6% |
| 2021 | 117.58 | +462.9% |
| 2020 | -32.40 | -343.5% |
| 2019 | -7.31 | -108.6% |
| 2018 | 84.89 | +855.1% |
| 2017 | 8.89 | +7211.8% |
| 2016 | -0.12 | - |